Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
The trial of the insulin-like growth factor-1 receptor (IGF-1R) inhibitor figitumumab in combination with carbo/taxol as first line therapy for advanced NSCLC was officially closed after it was determined that the experimental arm would not have a meaningful chance of appearing superior to standard carbo/taxol with a placebo ("futility analysis"). Dr. Sanborn had previously written about this trial after it was put on hold due to safety concerns with this combination.
Importantly, this agent is still being studied in combination with Tarceva, and that trial is still ongoing, as are trials with this agent in other cancers. It's not clear whether the safety concerns figitumumab in combination with chemo are specific to this one agent or whether other agents that inhibit the new target IGF-1R as a potentially important anti-cancer treatment will also show show safety problems and lack of efficacy in combination with chemo, nor do we know whether the issues are specific to carbo/taxol or could be a problem with other chemotherapy combinations.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi Revtoby, Welcome to Grace. I'm sorry you and your wife are worried about cancer but we couldn't say whether or not your wife's leison is cancer no matter how much...
Canyil, I'm sorry your father and you are going through this. While we can't give urgent help we are her to help offer info and resources to help make the best...
Hello and welcome to Grace. I'm sorry you're going through this worry. It is normal to watch a small very slow-growing solid nodule with once-a-year CT scans. Anything less than a...
Thanks you very much. So in summary the course of action taken suggested by lung specalist (re scan in 12 months) seems appropriate? And a PET at this stage is probably...
I can't say what is appropriate for you that's only something your professionals with all your information can do. However, when someone has a solid nodule less than a cm that...